Future Science Group

OCTalks: monitoring MRD in hematological malignancy management

Listen Later
In this interview we explore what minimal residual disease (MRD) is in hematological malignancies and how MRD is currently monitored. The interviewees also explain their recent research published in Nanomedicine, which investigates a novel tool to monitor hematological malignancies.
...more
View all episodesView all episodes
Download on the App Store
Future Science GroupBy Taylor & Francis Group
  • 5
  • 5
  • 5
  • 5
  • 5

5

2 ratings

More shows like Future Science Group

View all
Anesthesiology Journal's podcast by Anesthesiology, the journal of the American Society of Anesthesiologists

Anesthesiology Journal's podcast

47 Listeners

IEEE Brain by IEEE Brain

IEEE Brain

1 Listeners